drugset / Trial / NCT01416116

Method of Pre-treatment for Application of QUTENZA Capsaicin 8% Patch

NCT01416116

Phase 4 Completed 122 enrolled Astellas Pharma Inc
RandomizedParallel-groupSingle-blindTreatment

Summary

The Summary of product characteristics (SmPC) for QUTENZA advises that topical anaesthetic is applied prior to the application of QUTENZA. This is a multi-center, randomized, assessor-blinded study which will investigate the use of an oral analgesic as an alternative form of pre-treatment for QUTENZA.

Timeline

Start
2011-07-06
Primary completion
2012-04-25
Completion
2012-04-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Capsaicin Small molecule 8 % Topical
Subject Lidocaine Other / unclassified Topical
Subject Tramadol Other / unclassified Oral